Domů › Kolorektální karcinom › Oklahoma › Oklahoma City
Klinické studie Kolorektální karcinom v Oklahoma City, OK
22 studií pro Kolorektální karcinom hledá účastníky v lokalitách v Oklahoma City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- University of Oklahoma Health Sciences Center, Oklahoma City
Family Communications After Genetic Testing
Probíhá náborVítáni zdraví dobrovolníci
- Mercy Hospital Oklahoma City, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of Oklahoma, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Probíhá náborFáze 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Probíhá náborFáze 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Probíhá náborFáze 1/2
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- University of Oklahoma, Oklahoma City
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Probíhá náborFáze 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Clinical Study Site, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Probíhá náborFáze 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
Probíhá nábor
- TSET Health Promotion Research Center, Oklahoma City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Stephenson Cancer Center, Oklahoma City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- SSM OKC Hightower Clinical, Oklahoma City
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Probíhá náborFáze 2
- Hightower Clinical, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Probíhá náborObservační studie
- Mercy Hospital - OKC, Oklahoma City
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Probíhá náborFáze 1
- OU Stephenson Cancer Center, Oklahoma City
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Probíhá náborFáze 1
- OU Health Stephenson Cancer Center, Oklahoma City
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Probíhá náborFáze 3Vítáni zdraví dobrovolníci
- Mercy Hospital Oklahoma City, Oklahoma City
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- Mercy Hospital Oklahoma City, Oklahoma City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Probíhá náborObservační studie
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Studie Kolorektální karcinom v jiných městech
- Houston, TX102 studií
- New York City, NY78 studií
- Nashville, TN69 studií
- Boston, MA63 studií
- Los Angeles, CA59 studií
- Arlington, VA52 studií
- St. Louis, MO50 studií
- San Antonio, TX46 studií
- Philadelphia, PA44 studií
- Grand Rapids, MI40 studií
- Baldwin Park, CA37 studií
- Chicago, IL34 studií
Další studie v Oklahoma City
- Nemalobuněčný plicní karcinom28 studií
- Rakovina vaječníků28 studií
- Rakovina endometria25 studií
- Rakovina prostaty21 studií
- Rakovina plic19 studií
- Rakovina prsu17 studií
- Metastatický karcinom16 studií
- Rakovina (všechny typy)14 studií
- Akutní myeloidní leukemie14 studií
- Squamózní buněčný karcinom hlavy a krku13 studií
- Rakovina močového měchýře11 studií
- Rakovina slinivky břišní11 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.